Patients with asthma reminded of the increased risk of severe asthma attacks from overusing blue inhalers
This reminder follows updates to product information and the National Institute for Health and Care Excellence (NICE) guidance for short-acting beta 2 agonists (SABAs), including salbutamol and terbutaline, which are…